Copyright 2003 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2003
An alternative message can perhaps be derived from the article by Meyer et al.1 The article documents that INR was outside therapeutic range in 59% of patients receiving warfarin. The inference is that appropriate levels of anticoagulation control were not achieved in almost half. Is this acceptable? Is there a problem with the paradigm or is medication potency undependable?
Rothschild BM. Apparent Warfarin Potency Inconsistencies Compromise Effectiveness. Arch Intern Med. 2003;163(10):1243. doi:10.1001/archinte.163.10.1243-a
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: